Hong Kong biomedical innovation faces commercialization hurdles despite research strength

Hong Kong produces world-class medical research but struggles to translate it into commercial treatments due to cost, production, and regulatory challenges. The article highlights a robotic hand for stroke rehabilitation as an example of promising innovation stalled by these barriers. This matters as Hong Kong seeks to become a global biomedical hub, competing with regional peers.